newsit

Uncovering the Heart of Amphenol Corporation’s Q3 2024 Earnings Call: A Deep Dive into the Emotions and Insights Shared

Welcome to the Amphenol Corporation Q3 2024 Earnings Conference Call! Company Participants: – Craig Lampo, Chief Financial Officer – Adam Norwitt, Chief Executive Officer Conference Call Participants: – Andrew Buscaglia – BNP – Luke Junk – Baird – Amit Daryanani – Evercore – Samik Chatterjee – JPMorgan – Asiya Merchant – Citi – Joe Spak…

Read More

Revving Up for Success: A Recap of Lithia Motors Inc.’s Q3 2024 Earnings Call

Welcome to the Lithia Motors Q3 2024 Earnings Conference Call Company Participants Jardon Jaramillo – Senior Director, Investor Relations Bryan DeBoer – President and Chief Executive Officer Tina Miller – Senior Vice President and Chief Financial Officer Adam Chamberlain – Chief Operating Officer Chuck Lietz – Senior Vice President, Driveway Finance Conference Call Participants Ryan…

Read More

Uncovering the Retail Opportunity: A Recap of Retail Opportunity Investments Corp’s Q3 2024 Earnings Call

Welcome to Retail Opportunity Investments’ Third Quarter 2024 Conference Call Company Participants Lauren Silveira – Chief Accounting Officer Stuart Tanz – President and Chief Executive Officer Michael Haines – Chief Financial Officer Richard Schoebel – Chief Operating Officer Conference Call Participants Dori Kesten – Wells Fargo Securities Juan Sanabria – BMO Capital Markets Craig Mailman…

Read More

Unpacking the Q3 2024 Earnings Call of Atlas Copco AB (ATLKY): A Humorous and Quirky Recap

Atlas Copco AB (OTCPK:ATLKY) Q3 2024 Earnings Conference Call October 23, 2024 8:00 AM ET Company Participants Peter Kinnart – CFO Vagner Rego – CEO Conference Call Participants Daniela Costa – Goldman Sachs John Kim – Deutsche Bank Gustaf Schwerin – Handelsbanken Andrew Wilson – JPMorgan Klas Bergelind – Citi Sebastian Kuenne – RBC Andreas…

Read More

OKYO Pharma Takes a Step Towards Relief: First Patient Dosed in Groundbreaking Clinical Trial for Neuropathic Corneal Pain

Exciting News in Ophthalmology: OKYO Pharma Limited Begins Phase 2 Trial for OK-101 London and New York, Oct. 23, 2024 OKYO Pharma Limited, a leading ophthalmology-focused bio-pharmaceutical company, has recently announced a major milestone in the development of OK-101, a groundbreaking treatment for corneal neuropathic pain (NCP). NCP is an ocular condition characterized by pain,…

Read More